Clinical Trial Update: Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating colesevelam for diarrhea-predominant irritable bowel syndrome with bile acid malabsorption has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Acid Malabsorption
• Diarrhea
• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• Colesevelam (colesevelam)

Snippet

Sponsor: Mayo Clinic | Conditions: Chronic Diarrhea, Irritable Bowel Syndrome With Diarrhea | Phase 2 | Status: COMPLETED | Results posted: 2020-04-27